| Timothy L Tam, MD | |
|
2240 Ridgewood Rd, Ste 100, Wyomissing, PA 19610-1167 | |
| (610) 376-8691 | |
| (610) 376-8745 |
| Full Name | Timothy L Tam |
|---|---|
| Gender | Male |
| Speciality | Pediatric Medicine |
| Experience | 23 Years |
| Location | 2240 Ridgewood Rd, Wyomissing, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598769580 | NPI | - | NPPES |
| 1010441290001 | Medicaid | PA | |
| 06036 | Other | PA | EPSDT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD424019 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morgantown Family Practice Llc | 0244207322 | 3 |
News Archive
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
Up to 18 percent of babies born worldwide arrive before they are full-term, defined as 37 weeks of gestation. About 1 million of those babies do not survive, and those who do can face developmental problems such as impaired vision or hearing, defects in the heart or lungs, or cognitive impairments.
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Improving transversus abdominis slide appears to be associated with clinically important long-term pain reduction in people experiencing lower back pain, researchers report.
› Verified 6 days ago
| Entity Name | Morgantown Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710958475 PECOS PAC ID: 0244207322 Enrollment ID: O20040916001022 |
News Archive
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
Up to 18 percent of babies born worldwide arrive before they are full-term, defined as 37 weeks of gestation. About 1 million of those babies do not survive, and those who do can face developmental problems such as impaired vision or hearing, defects in the heart or lungs, or cognitive impairments.
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Improving transversus abdominis slide appears to be associated with clinically important long-term pain reduction in people experiencing lower back pain, researchers report.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy L Tam, MD 2240 Ridgewood Rd, Ste 100, Wyomissing, PA 19610-1167 Ph: (610) 376-8691 | Timothy L Tam, MD 2240 Ridgewood Rd, Ste 100, Wyomissing, PA 19610-1167 Ph: (610) 376-8691 |
News Archive
The Joint Canada-Israel Health Research Program is a seven-year, CA$35 million partnership between the Azrieli Foundation, Canada's International Development Research Centre, the Canadian Institutes of Health Research, and the Israel Science Foundation that draws on the scientific strengths of Canadian and Israeli researchers in the broad field of biomedicine.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
Up to 18 percent of babies born worldwide arrive before they are full-term, defined as 37 weeks of gestation. About 1 million of those babies do not survive, and those who do can face developmental problems such as impaired vision or hearing, defects in the heart or lungs, or cognitive impairments.
Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.
Improving transversus abdominis slide appears to be associated with clinically important long-term pain reduction in people experiencing lower back pain, researchers report.
› Verified 6 days ago
Tiffany L. Sergi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-4252 | |
Joe K. George, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Suite 1, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-4252 | |
Robert J Cordes, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2240 Ridgewood Rd, Ste 100, Wyomissing, PA 19610 Phone: 610-376-8691 Fax: 610-376-8745 | |
Sanand R. Menon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-4252 | |
Amanda Lynn Gosling, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Suite 1, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-1641 | |
Jennifer L Watson, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 40 Berkshire Ct, Suite 1, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-1641 | |
Mark S. Reuben, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 40 Berkshire Ct, Wyomissing, PA 19610 Phone: 610-374-7400 Fax: 610-374-1641 |